☆ 4.6 Review

New Opportunities for the Utilization of the Sulfoximine Group in Medicinal Chemistry from the Drug Designer's Perspective

CHEMISTRY-A EUROPEAN JOURNAL (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy

Jennifer R. Diamond et al.

Summary: This study reports the first-in-human phase I study of VIP152, a highly selective cyclin-dependent kinase 9 (CDK9) inhibitor. The results show that VIP152 monotherapy demonstrated a favorable safety profile and evidence of clinical benefit in patients with advanced high-grade B-cell lymphoma and solid tumors.

CLINICAL CANCER RESEARCH (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Recent Developments in PROTAC-Mediated Protein Degradation: From Bench to Clinic

Zhenyi Hu et al.

Summary: PROTACs are an emerging technology that utilizes the ubiquitin-proteasome system for targeted protein degradation, showing great therapeutic potential in treating diseases. Over the past two decades, significant advancements have been made in PROTAC technology, with an increasing repertoire of targets.

CHEMBIOCHEM (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

The importance of sulfur-containing motifs in drug design and discovery

Muhamad Mustafa et al.

Summary: Sulfur-containing functional groups play a significant role in medicinal chemistry and drug discovery. They have diverse applications and are found in a wide range of pharmacologically effective substances. The study reviews the recent research on organosulfur-based drug discovery and highlights the potential of sulfur-based compounds in lead compound development. Despite the growing importance of sulfur in medicinal chemistry, there is still a need for further exploration and development of synthetic methodologies for these functional groups.

EXPERT OPINION ON DRUG DISCOVERY (2022)

添加到收藏夹

Article Chemistry, Medicinal

The Ascension of Targeted Covalent Inhibitors

Juswinder Singh

Summary: Covalent drugs have had a significant impact on human health, but they were previously avoided by the pharmaceutical industry due to concerns about potential toxicity. However, there has been a resurgence in interest with the clinical success of targeted covalent inhibitors (TCIs) and the approval of eight drugs in the past decade. The ability to create unique drugs through the covalent mechanism of action has led to clinically decisive target product profiles. TCIs have revolutionized the treatment approach for non-small-cell lung cancer and chronic lymphocytic leukemia. This Perspective article highlights the clinical and financial success of this drug class and provides early insights into toxicity, a previously hindering factor in the field.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Clinical considerations for the design of PROTACs in cancer

Cristina Nieto-Jimenez et al.

Summary: The development of protein degradation drugs (PROTACs) is of great importance in cancer treatment. By selecting the appropriate proteins as degradation targets and ubiquitin ligases that are highly expressed in tumor cells but not in normal tissues, the efficacy of treatment can be enhanced while minimizing toxicity.

MOLECULAR CANCER (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Sulfondiimidamides as new functional groups for synthetic and medicinal chemistry

Ze-Xin Zhang et al.

Summary: Sulfonamides, with their unique structure and properties, play a significant role in designing bioactive molecules. Mono aza variants, sulfonimidamides, and double aza analogs, sulfondiimidamides, are two functional groups. However, the synthesis of sulfondiimidamides is challenging, and their assembly and modification can be achieved through specific methods.

CHEM (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Recent progress in covalent warheads for in vivo targeting of endogenous proteins

Naoya Shindo et al.

Summary: Covalent drugs modify endogenous target proteins to exert potent and durable activity, with current focus on developing targeted covalent inhibitors (TCIs) to maximize efficacy and minimize toxicity risks. The characteristics of warheads affect the target selectivity of TCIs.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Review Chemistry, Medicinal

Application of sulfoximines in medicinal chemistry from 2013 to 2020

Yu Han et al.

Summary: Interest in sulfoximine chemistry has increased in recent years, with several sulfoximine-containing drugs entering clinical trials. However, limited experience in physicochemical and in vitro parameters of sulfoximines hampers their routine application in drug discovery. This review aims to provide support for the addition of sulfoximine components in medicinal chemists' toolbox.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Generation of potent Nrf2 activators via tuning the electrophilicity and steric hindrance of vinyl sulfones for neuroprotection

Zi-Long Song et al.

Summary: Oxidative stress plays a role in the development of neurodegenerative diseases, and targeting oxidative stress is a promising strategy for treatment. Small molecules that interfere with cellular redox-regulating machinery, such as compounds 9b and 9c, show neuroprotective effects by upregulating antioxidant genes through the Nrf2 pathway, making them potential candidates for further development as neuroprotective agents.

BIOORGANIC CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion

Xiaqiu Qiu et al.

Summary: CDK9 inhibitor BAY-1143572 converted into PROTACs leads to degradation of CDK9 in acute myeloid leukemia cells, with the most potent molecule B03 showing enhanced antiproliferative activity. This enhanced activity is mediated by increased kinase inhibitory activity and apoptosis induction levels. B03 can also induce CDK9 degradation in vivo, indicating its potential as a therapeutic strategy in acute myeloid leukemia.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Review Oncology

Unlocking the potential of antibody-drug conjugates for cancer therapy

Joshua Z. Drago et al.

Summary: Nine ADCs are currently approved for cancer treatment, with many more in development. Advances in synthetic biochemistry have led to a new generation of ADCs promising improved tissue specificity and cytotoxicity. Despite impressive activity against treatment-refractory cancers, challenges such as systemic toxicity and acquired resistance remain. This review discusses the design, mechanism of action, and limitations of ADCs, proposing strategies to maximize their therapeutic benefit for cancer patients.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Chemistry, Organic

Synthesis and Configurational Assignment of Vinyl Sulfoximines and Sulfonimidamides

Gregory B. Craven et al.

Summary: Vinyl sulfoximines and sulfonimidamides, as S(VI) aza-isosteres of vinyl sulfones and sulfonamides, have been less studied and not yet applied to protein bioconjugation. This study reports various synthetic methodologies for constructing these structures, demonstrating their application in generating fully functionalized probes. Furthermore, a workflow for determining the absolute configuration of enantioenriched vinyl sulfoximines and sulfonimidamides is established.

JOURNAL OF ORGANIC CHEMISTRY (2021)

添加到收藏夹

Review Biochemical Research Methods

An Overview of Recent Advances in Biomedical Applications of Click Chemistry

Jasleen Kaur et al.

Summary: Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) is a modular and bio-orthogonal approach for efficient synthesis of organic and bioorganic compounds, leading to the selective formation of 1,4-disubstituted 1,2,3-triazole units with fast reaction kinetics and high chemospecificity. Its applications in pharmaceutical research range from developing anticancer, antibacterial, and antiviral agents to biomedical imaging agents and clinical therapeutics.

BIOCONJUGATE CHEMISTRY (2021)

添加到收藏夹

Review Chemistry, Multidisciplinary

Synthesis and Transformations of NH-Sulfoximines

Michael Andresini et al.

Summary: In recent years, there has been a significant increase in the use of sulfoximines in the field of chemistry, as they are considered valuable motifs in medicinal chemistry, due to pioneering works in clinical trials and the development of synthetic methods. Recent developments in sulfoximine synthesis, focusing on S-N and S-C bond formations since 2015, as well as the use of flow chemistry processes and subsequent transformations, particularly in N-functionalization, have been covered in this review.

CHEMISTRY-A EUROPEAN JOURNAL (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Towards the Development of Orally Available Peptide Therapeutics

Xu-Dong Kong et al.

Summary: Peptides have attractive properties for drug development, but poor oral availability limits their application. The majority of approved peptide drugs are not orally applicable. More research and efforts are needed to overcome this barrier.

CHIMIA (2021)

添加到收藏夹

Editorial Material Pharmacology & Pharmacy

How do we address neglected sulfur pharmacophores in drug discovery?

Michael J. Tilby et al.

EXPERT OPINION ON DRUG DISCOVERY (2021)

添加到收藏夹

Article Chemistry, Medicinal

Changing for the Better: Discovery of the Highly Potent and Selective CDK9 Inhibitor VIP152 Suitable for Once Weekly Intravenous Dosing for the Treatment of Cancer

Ulrich Luecking et al.

Summary: Selective inhibition of CDK9, starting from atuveciclib and leading to the discovery of the potent inhibitor VIP152, has shown promising preclinical efficacy and good tolerability. VIP152 has entered clinical trials and demonstrated longterm, durable monotherapy activity in specific cancer patients.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Editorial Material Chemistry, Multidisciplinary

Combining biological and chemical diversity

Christian Heinis

NATURE CHEMISTRY (2021)

添加到收藏夹

Article Cell Biology

A helicase-primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections

Christian Gege et al.

Summary: The text discusses the high prevalence of chronic herpesvirus infections and introduces a new HSV helicase-primase inhibitor, IM-250, with potential in vitro anti-herpes activity. IM-250 shows advantages over standard-of-care therapies in reducing disease duration, preventing recurrence, and maintaining effectiveness post-treatment cessation.

SCIENCE TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Generation of a 100-billion cyclic peptide phage display library having a high skeletal diversity

Vanessa Carle et al.

Summary: Phage display is a powerful technique used for generating peptide- or protein-based ligands, and the success of selections depends on library size and diversity. A newly developed phage display library with around 100 billion (bi)cyclic peptides has been created by combining a novel library cloning technique with a small plasmid for bacterial transformation. This high diversity library, based on 273 different peptide backbones, allowed the enrichment of high-affinity peptides against a thrombosis target.

PROTEIN ENGINEERING DESIGN & SELECTION (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Increasing Complexity: A Practical Synthetic Approach to Three-Dimensional, Cyclic Sulfoximines and First Insights into Their in Vitro Properties

Emilie Boulard et al.

CHEMISTRY-A EUROPEAN JOURNAL (2020)

添加到收藏夹

Article Clinical Neurology

Characterization of More Selective Central Nervous System Nrf2-Activating Novel Vinyl Sulfoximine Compounds Compared to Dimethyl Fumarate

Karl E. Carlstrom et al.

NEUROTHERAPEUTICS (2020)

添加到收藏夹

Article Chemistry, Medicinal

Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update

Tizhi Wu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Medicinal

Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry

Patrick Maeder et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

TMTHSI, a superior 7-membered ring alkyne containing reagent for strain-promoted azide-alkyne cycloaddition reactions

Jimmy Weterings et al.

CHEMICAL SCIENCE (2020)

添加到收藏夹

Review Chemistry, Medicinal

New evolutions in the BACE1 inhibitor field from 2014 to 2018

Chien-Chi Hsiao et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

添加到收藏夹

Review Chemistry, Medicinal

Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review

Chuang Zhao et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

添加到收藏夹

Article Chemistry, Medicinal

Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology

Matthias Gehringer et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

添加到收藏夹

Article Chemistry, Medicinal

Sulfoximines as potent RORc inverse agonists

Gilles Ouvry et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

添加到收藏夹

Article Chemistry, Organic

Palladium-Catalyzed N-Arylation of Sulfoximines with Aryl Sulfonates

Qingjing Yang et al.

JOURNAL OF ORGANIC CHEMISTRY (2018)

添加到收藏夹

Article Chemistry, Organic

Route scouting and optimization of a potent sulfoximine-based inverse agonist of RORγt

Guillaume Lafitte et al.

TETRAHEDRON (2018)

添加到收藏夹

Article Chemistry, Medicinal

Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent

Kevin M. Foote et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

添加到收藏夹

Article Chemistry, Medicinal

Sulfoximines from a Medicinal Chemist's Perspective: Physicochemical and in vitro Parameters Relevant for Drug Discovery

Marcus Frings et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR Inhibitors

Yipin Lu et al.

JOURNAL OF MOLECULAR BIOLOGY (2017)

添加到收藏夹

Article Chemistry, Medicinal

Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer

Ulrich Luecking et al.

CHEMMEDCHEM (2017)

添加到收藏夹

Review Chemistry, Medicinal

Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates

Juan Alberto Sirvent et al.

CHEMMEDCHEM (2017)

添加到收藏夹

Review Chemistry, Multidisciplinary

Sulfonimidamides in Medicinal and Agricultural Chemistry

Praveen K. Chinthakindi et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)

添加到收藏夹

Article Chemistry, Medicinal

Recent progress on nuclear receptor RORγ modulators

Patrick Cyr et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

添加到收藏夹

Review Infectious Diseases

Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management

Jocelyne Piret et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Designing novel building blocks is an overlooked strategy to improve compound quality

Frederick W. Goldberg et al.

DRUG DISCOVERY TODAY (2015)

添加到收藏夹

Article Pharmacology & Pharmacy

A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model

Ji Ae Lee et al.

BRITISH JOURNAL OF PHARMACOLOGY (2015)

添加到收藏夹

Article Chemistry, Multidisciplinary

Sulfoximines: A Neglected Opportunity in Medicinal Chemistry

Ulrich Luecking

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)

添加到收藏夹

Article Chemistry, Medicinal

The Lab Oddity Prevails: Discovery of Pan-CDK Inhibitor (R)-S-Cyclopropyl-S-(4-{[4-{[(1R,2R)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide (BAY1000394) for the Treatment of Cancer

Ulrich Luecking et al.

CHEMMEDCHEM (2013)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity

Kevin M. Foote et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

添加到收藏夹

Article Agriculture, Multidisciplinary

Discovery and Characterization of Sulfoxaflor, a Novel Insecticide Targeting Sap-Feeding Pests

Yuanming Zhu et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)

添加到收藏夹

Article Chemistry, Medicinal

Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design

Nicholas A. Meanwell

JOURNAL OF MEDICINAL CHEMISTRY (2011)

添加到收藏夹

Review Chemistry, Multidisciplinary

Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality

Ellen M. Sletten et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)

添加到收藏夹

Article Oncology

A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI™), in patients with advanced solid tumours

Edwina N. Scott et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)

添加到收藏夹

Article Chemistry, Medicinal

Design and synthesis of sulfoximine based inhibitors for HIV-1 protease

Abbas Raza et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

添加到收藏夹

Article Oncology

Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery)

Janet S. Graham et al.

EUROPEAN JOURNAL OF CANCER (2008)

添加到收藏夹

Article Medicine, Research & Experimental

Molecular and pharmacodynamic characteristics of the novel multi-target tumor growth inhibitor ZK 304709

G. Siemeister et al.

BIOMEDICINE & PHARMACOTHERAPY (2006)

添加到收藏夹

Article Pharmacology & Pharmacy

Drug discovery and commercial exploitation

G Satzinger

DRUG NEWS & PERSPECTIVES (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.